| scholarly article | Q13442814 |
| P2093 | author name string | S Matsumoto | |
| M Ito | |||
| T Tanaka | |||
| T Takayama | |||
| S Nakamura | |||
| Y Nakajima | |||
| K Migita | |||
| K Enomoto | |||
| T Akahori | |||
| M Sho | |||
| K Wakatsuki | |||
| P2860 | cites work | Adoptive cell transfer: a clinical path to effective cancer immunotherapy | Q24644774 |
| Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 | ||
| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
| A new era for cancer immunotherapy based on the genes that encode cancer antigens | Q28141612 | ||
| Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer | Q28245751 | ||
| High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma | Q33739931 | ||
| Effector memory T cells, early metastasis, and survival in colorectal cancer | Q33992461 | ||
| The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity | Q34232543 | ||
| Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model | Q34420239 | ||
| Clinical relevance of Fas expression in oesophageal squamous cell carcinoma. | Q35769531 | ||
| Novel targeted therapies in the treatment of gastric and esophageal cancer | Q36175741 | ||
| Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma | Q36608555 | ||
| The adaptive immunologic microenvironment in colorectal cancer: a novel perspective | Q36749070 | ||
| Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas | Q36869621 | ||
| Chemoradiation in the management of esophageal cancer | Q36935105 | ||
| Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer | Q36977523 | ||
| Resection for esophageal cancer: strategies for optimal management | Q37067954 | ||
| Fine tuning the immune response through B7-H3 and B7-H4 | Q37227080 | ||
| Homeostasis of naive and memory T cells | Q37356053 | ||
| Clinical importance of B7-H3 expression in human pancreatic cancer | Q37424100 | ||
| Lessons from an aggressive cancer: evolutionary dynamics in esophageal carcinoma | Q37528826 | ||
| Perioperative management of esophageal cancer | Q37704944 | ||
| Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family | Q37864700 | ||
| Effective therapeutic targeting of the overexpressed HER-2 receptor in a highly metastatic orthotopic model of esophageal carcinoma | Q39683755 | ||
| Tumor antigens recognized by T lymphocytes | Q40661131 | ||
| Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagus | Q46704881 | ||
| Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma | Q47804896 | ||
| The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. | Q48032094 | ||
| Lifespan of human lymphocyte subsets defined by CD45 isoforms | Q52069544 | ||
| Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival. | Q53265013 | ||
| Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. | Q54287306 | ||
| CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma | Q73205095 | ||
| Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers | Q79157496 | ||
| Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer | Q84291849 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 186-191 | |
| P577 | publication date | 2012-05-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma. | |
| P478 | volume | 168 |
| Q53647584 | Association between the genetic variations within TBX21 gene promoter and the clinicopathological characteristics of esophageal squamous cell carcinoma in a high-risk Chinese population. |
| Q36378871 | CD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer. |
| Q37594349 | Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma |
| Q36871188 | Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice |
| Q89173146 | Memory CD4+ T cell subsets in tumor draining lymph nodes of breast cancer patients: A focus on T stem cell memory cells |
| Q35294099 | Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer |
| Q39132920 | Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma |
| Q39061519 | Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma |
| Q47224779 | Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model |
| Q41673328 | Tumor-infiltrating CD45RO(+) memory cells are associated with a favorable prognosis breast cancer |
| Q41606742 | Tumor-infiltrating CD45RO+ Memory T Lymphocytes Predict Favorable Clinical Outcome in Solid Tumors |
| Q39777761 | Tumor-infiltrating memory T-lymphocytes for prognostic prediction in cancer patients: a meta-analysis |
Search more.